These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
293 related items for PubMed ID: 10461898
1. Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitro. Szabo B, Müller T, Koch H. J Neurochem; 1999 Sep; 73(3):1084-9. PubMed ID: 10461898 [Abstract] [Full Text] [Related]
2. Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids. Szabo B, Siemes S, Wallmichrath I. Eur J Neurosci; 2002 Jun; 15(12):2057-61. PubMed ID: 12099913 [Abstract] [Full Text] [Related]
3. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex. Heijna MH, Padt M, Hogenboom F, Portoghese PS, Mulder AH, Schoffelmeer AN. Eur J Pharmacol; 1990 Jun 08; 181(3):267-78. PubMed ID: 2166675 [Abstract] [Full Text] [Related]
4. Neurochemical evidence that stimulation of CB1 cannabinoid receptors on GABAergic nerve terminals activates the dopaminergic reward system by increasing dopamine release in the rat nucleus accumbens. Sperlágh B, Windisch K, Andó RD, Sylvester Vizi E. Neurochem Int; 2009 Jun 08; 54(7):452-7. PubMed ID: 19428788 [Abstract] [Full Text] [Related]
5. Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum. Cadogan AK, Alexander SP, Boyd EA, Kendall DA. J Neurochem; 1997 Sep 08; 69(3):1131-7. PubMed ID: 9282935 [Abstract] [Full Text] [Related]
6. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids. Hoffman AF, Lupica CR. J Neurophysiol; 2001 Jan 08; 85(1):72-83. PubMed ID: 11152707 [Abstract] [Full Text] [Related]
7. Analysis of the effect of cannabinoids on GABAergic neurotransmission in the substantia nigra pars reticulata. Wallmichrath I, Szabo B. Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr 08; 365(4):326-34. PubMed ID: 11919658 [Abstract] [Full Text] [Related]
8. Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. Szabo B, Dörner L, Pfreundtner C, Nörenberg W, Starke K. Neuroscience; 1998 Jul 08; 85(2):395-403. PubMed ID: 9622239 [Abstract] [Full Text] [Related]
9. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. Gerdeman G, Lovinger DM. J Neurophysiol; 2001 Jan 08; 85(1):468-71. PubMed ID: 11152748 [Abstract] [Full Text] [Related]
10. Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis. Köfalvi A, Rodrigues RJ, Ledent C, Mackie K, Vizi ES, Cunha RA, Sperlágh B. J Neurosci; 2005 Mar 16; 25(11):2874-84. PubMed ID: 15772347 [Abstract] [Full Text] [Related]
11. Effects of cannabinoids on adrenaline release from adrenal medullary cells. Niederhoffer N, Hansen HH, Fernandez-Ruiz JJ, Szabo B. Br J Pharmacol; 2001 Nov 16; 134(6):1319-27. PubMed ID: 11704653 [Abstract] [Full Text] [Related]
12. Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats. Cheer JF, Wassum KM, Heien ML, Phillips PE, Wightman RM. J Neurosci; 2004 May 05; 24(18):4393-400. PubMed ID: 15128853 [Abstract] [Full Text] [Related]
13. D2 receptor-mediated inhibition of dopamine release in the rat striatum in vitro is modulated by CB1 receptors: studies using fast cyclic voltammetry. O'Neill C, Evers-Donnelly A, Nicholson D, O'Boyle KM, O'Connor JJ. J Neurochem; 2009 Feb 05; 108(3):545-51. PubMed ID: 19187091 [Abstract] [Full Text] [Related]
14. Mechanisms of Kappa Opioid Receptor Potentiation of Dopamine D2 Receptor Function in Quinpirole-Induced Locomotor Sensitization in Rats. Escobar AP, González MP, Meza RC, Noches V, Henny P, Gysling K, España RA, Fuentealba JA, Andrés ME. Int J Neuropsychopharmacol; 2017 Aug 01; 20(8):660-669. PubMed ID: 28531297 [Abstract] [Full Text] [Related]
15. Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study. Pistis M, Muntoni AL, Pillolla G, Gessa GL. Eur J Neurosci; 2002 Jun 01; 15(11):1795-802. PubMed ID: 12081659 [Abstract] [Full Text] [Related]
16. The cannabinoid agonists WIN 55,212-2 and CP 55,940 attenuate rotational behavior induced by a dopamine D1 but not a D2 agonist in rats with unilateral lesions of the nigrostriatal pathway. Anderson LA, Anderson JJ, Chase TN, Walters JR. Brain Res; 1995 Sep 11; 691(1-2):106-14. PubMed ID: 8590042 [Abstract] [Full Text] [Related]
17. Cannabinoids depress excitatory neurotransmission between the subthalamic nucleus and the globus pallidus. Freiman I, Szabo B. Neuroscience; 2005 Sep 11; 133(1):305-13. PubMed ID: 15893652 [Abstract] [Full Text] [Related]
18. D2 autoreceptor switches CB2 receptor effects on [3 H]-dopamine release in the striatum. López-Ramírez G, Sánchez-Zavaleta R, Ávalos-Fuentes A, José Sierra J, Paz-Bermúdez F, Leyva-Gómez G, Segovia Vila J, Cortés H, Florán B. Synapse; 2020 Mar 11; 74(3):e22139. PubMed ID: 31610050 [Abstract] [Full Text] [Related]
19. Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure. Hoffman AF, Oz M, Caulder T, Lupica CR. J Neurosci; 2003 Jun 15; 23(12):4815-20. PubMed ID: 12832502 [Abstract] [Full Text] [Related]
20. Differential effects of dopamine agonists on evoked dopamine release from slices of striatum and nucleus accumbens in rats. Yamada S, Yokoo H, Nishi S. Brain Res; 1994 Jun 13; 648(1):176-9. PubMed ID: 7922522 [Abstract] [Full Text] [Related] Page: [Next] [New Search]